DeRoyal FACIAL PACK PGYBK, REF 89-10007.03
Published December 21, 2022 · Recall initiated: November 3, 2022
Summary
FDA records medical device Class II recall Z-0668-2023, published December 21, 2022 and initiated November 3, 2022. Recalling firm: DeRoyal Industries Inc; Status: Ongoing; Reported quantity: 35 kits; Lot: Lot Numbers: Lot 55968449 exp 1/1/2024; Lot 56619751 exp 4/1/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
XXX
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- DeRoyal Industries Inc
- Distributor
- US: Tennessee, Texas, New York, Wisconsin, Florida, Virginia, Massachusetts, Arizona, Missouri, Connecticut, New Jersey, Pennsylvania, North Carolina, Louisiana, Michigan, Minnesota, Ohio, Indiana, Kansas, Illinois, Alabama, Georgia, Mississippi
- Lot
- Lot Numbers: Lot 55968449 exp 1/1/2024; Lot 56619751 exp 4/1/2024
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAREF: 81-030415 Myocardial Probe Non-Pyrogenic , 400 SeriesSeptember 30, 2026
- FDADeRoyal Industries Inc. Ref 46-406, Covaderm Plus, Vascular Access Dressing 6"x6" (15cmx15cm)June 10, 2026
- FDADeRoyal CHILDREN'S LAPTRACEPACK, 89-9362.06November 13, 2024
- FDADeRoyal C-SECTION TRACEPACK, REF 89-9338-06November 13, 2024
- FDADeRoyal LUMBAR/CERVICAL PACK, REF 89-9521.11December 21, 2022
- FDADeRoyal SHOULDER ARTHOSCOPY PACK, REF 89-10240.03December 21, 2022
Questions about this recall
Was DeRoyal FACIAL PACK PGYBK, REF 89-10007.03 recalled?
Yes. FDA published recall Z-0668-2023 on December 21, 2022. Reported hazard: XXX
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit